Skip to Main Content

C4 Gene Dose Effects using 11C-UCB-J PET

Conditions

Diseases of the Nervous System | Mental Health & Behavioral Research

Phase Pilot

What is the purpose of this trial?

The primary investigational aim of this study is to determine whether increasing genetic dose of schizophrenia-associated risk alleles at the C4 gene are associated (negatively correlated) with regional synaptic density in the living human brain as measured by 11C-UCB-J PET.

  • Trial with
    Brain and Behavior Research Foundation
  • Start Date
    04/02/2018
  • End Date
    01/31/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000022444